The QualityStocks Daily Monday, December 16th, 2019

Today's Top 3 Investment Newsletters

StockMarketWatch (MIRM) +110.99%

MarketClub Analysis (AXSM) +70.55%

QualityStocks (MMMB) +30.35%

The QualityStocks Daily Stock List

Abacus Health Products, Inc. (ABAHF)

New Cannabis Ventures, Morningstar, Penny Stock Hub, Cannanbindex.co, OTC Markets, InvestorX, Stockhouse, Dividend Investor, Stockwatch, Market Wire News, TradingView, Investors Hangout, Market Screener, and TipRanks reported earlier on Abacus Health Products, Inc. (ABAHF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Abacus Health Products, Inc. manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemp. The OTCQB-listed Company targets its products at the fast growing markets for topical pain relief and therapeutic skincare. Its products are based on proprietary patent-pending technologies developed by Abacus. Abacus Health Products is a subsidiary of Aidance Skincare & Topical Solutions, LLC.

Abacus Health Products was formed with a mission to use CBD hemp extract (Cannabis sativa L) as a conduit to deliver the world’s quickest and most effective pain relief products to millions of people globally. In essence, Abacus engages in the development and commercialization of OTC registered topical medications with active pharmaceutical ingredients. These contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD (cannabidiol) from the Cannabis sativa L plant.

Abacus currently offers two lines of products. One is CBD CLINIC™, marketed to the professional practitioner market. The other is CBDMEDIC™, marketed to the consumer market. The Company’s products are offered throughout the United States. They are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.

Abacus Health Products is the first company to secure OTC registrations for a suite of products blended with CBD hemp extract (Cannabis sativa L). It started distribution to healthcare practitioners in 2016 under the CBD CLINIC brand name. In Q3 of 2018, Abacus launched CBDMEDIC directly to the active fitness and mass retail markets.

CBD CLINIC products are formulated to support fast and lasting relief from joint and muscle pain. A proprietary blend of natural emollients facilitates deeper and quicker absorption of pain-relieving compounds to interrupt pain signaling. In addition, CBDMEDIC products use only naturally-derived analgesic ingredients and 100 percent natural oils to help speed up absorption. The CBDMEDIC line is segmented into three product categories. These are Active Sport, Back & Neck and Arthritis.

Last week, Landrace Bioscience, Inc., a science and research-driven hemp ingredient manufacturer and leader in custom product formulation solutions, announced its partnership with Abacus Health Products. Landrace Bioscience will immediately start supplying hemp extracts for Abacus' leading over-the-counter, non-prescription topical brands, CBDMEDIC™ and CBDCLINIC™. The company will also be working with Abacus to develop new products for former professional football champion and Abacus spokesperson, Rob Gronkowski's, upcoming cannabidiol (CBD) line.

For Q3 2019, Abacus Health Products’ Revenue increased 97.4 percent YoY (Year over Year) to $4.1 million and sequentially 26.4 percent from Q2 2019. Gross Profit increased 100 percent YoY to $2.4 million and sequentially 24.0 percent from Q2 2019. Gross Margin increased YoY to 60.1 percent from 59.3 percent.

Abacus Health Products, Inc. (ABAHF), closed Monday's trading session at $4.4625, up 0.056054%, on 1,583 volume with 8 trades. The average volume for the last 3 months is 11,491 and the stock's 52-week low/high is $3.00/$14.00.

Advantage Lithium Corp. (AVLIF)

The Bull Report, Streetwise Reports, OTC Markets, Investing News, Nasdaq, Morningstar, InvestorsHub, The Prospector News, Gold Telegraph, Street Insider, Macroaxis, Market Wire News, TMXmoney, Junior Mining Network, Mining News Feed, StockInvest.us, Market Screener, TipRanks, Stockhouse, Wallet Investor, TradingView, Wallmine, GuruFocus, Investors Hangout, and GlobeNewswire reported beforehand on Advantage Lithium Corp. (AVLIF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Advantage Lithium Corp. focuses on developing its 75 percent owned Cauchari lithium project, located in Jujuy, Argentina (75 percent Advantage Lithium, 25 percent Orocobre Ltd.). Additionally, the Company owns 100 percent interest in three additional lithium exploration properties in Argentina. These are Antofalla, Incahuasi, and Guayatayoc. OTCQX-listed, Advantage Lithium is based in Vancouver, British Columbia.

Advantage Lithium is a lithium explorer and developer with top tier management and an international portfolio of quality assets. The Company has a partnership with Orocobre, one of Argentina’s foremost lithium producers, to develop its Cauchari asset. This asset hosts an inferred resource and includes a large exploration target. Orocobre is the largest single shareholder of Advantage Lithium.

The Cauchari Project encompasses about 28,000 hectares. It is less than 20km south of Orocobre’s producing Olaroz Plant. The Project is adjacent to an international highway and has access to water and power. The Permitting process established with local governments is supportive. Orocobre is the only new lithium brine producer in the past 20 years. More than US $600M has been committed to developing the Cauchari-Olaroz basin in the past 12 months (as of May 2019).

In October 2019, Advantage Lithium announced the results of a Pre-Feasibility Study (PFS) based on production of Battery Grade Lithium Carbonate from a 25 ktpa nameplate capacity stand-alone plant at its Cauchari JV in the province of Jujuy, Argentina.

Callum Grant , Interim Chief Executive Officer, said "The PFS now demonstrates that we have a solid project to a much improved level of confidence compared to the 2018 Preliminary Economic Assessment. Not only have we doubled the resource but more importantly those resources were upgraded to Measured and Indicated categories earlier in 2019. Now we have a Proven and Probable Mineral Reserve demonstrating the economic viability of the asset to support long-life supply of battery-grade Lithium Carbonate to the EV market; we're now at a different level where the value of the asset is clear.

In late November, Advantage Lithium announced that it filed the full PFS Technical Report on its Cauchari JV project. The PFS was completed by independent consulting firms FloSolution and Worley.

Advantage Lithium Corp. (AVLIF), closed Monday's trading session at $0.136584, up 5.0646%, on 70,117 volume with 20 trades. The average volume for the last 3 months is 38,556 and the stock's 52-week low/high is $0.101599998/$0.546564996.

AVRA Medical Robotics, Inc. (AVMR)

Financial Buzz, TipRanks, VentureLine, last10k, GuruFocus, Market Screener, BioSpace, MarketWatch, Nasdaq, Dividend Investor, Market Wire News, Global Banking and Finance, Seeking Alpha, Wallet Investor, Stockhouse, otc.watch, GlobeNewswire, Dividend.com, Stockopedia, TradingView, and Simply Wall St reported previously on AVRA Medical Robotics, Inc. (AVMR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AVRA Medical Robotics, Inc. is building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence (AI), machine learning and proprietary software. The Company is modernizing the practice of surgery by developing a fully autonomous medical robotic system that “robotizes” a broad range of medical procedures presently being performed by human hands using surgical and non-surgical devices and instruments. AVRA Medical Robotics’ shares trade on the OTC Markets’ OTCQB. The Company is based in Orlando, Florida.

The Company’s medical team were among the earliest adopters to perform robotically assisted, minimally-invasive surgery. AVRA Medical Robotics’ Surgeons are partnering with engineers and scientists to design and develop a novel, computer-integrated, semi/autonomous robotic platform that is truly disruptive. AVRA is designing systems that will enable surgeons to simulate procedures for preoperative review before performing surgery.

Regarding Instrument Guidance, the proprietary intelligent AVRA Instrument Guidance System (AIGS) will bring precise navigation and accurate targeting to robotic surgery. This will result in a Surgeon interfaced autonomous platform. Concerning Imaging, the Company’s imaging technology will be capable of high-resolution, multi-dimensional imaging with incorporated scanning and registration. AVRA’s technology will be flexible and applicable across a varied range of medical disciplines. Moreover, AVRA is using its technology to develop ways of significantly improving biopsy result waiting times from weeks or days to minutes.

In August of this year, AVRA Medical Robotics announced that its regulatory and management teams met with the Food and Drug Administration (FDA) on August 12, 2019. AVRA’s robot arm has already won approval in the EU and received the CE mark. The Company has started implementing a quality and regulatory system, which will serve as the foundation for U.S., Canadian, European, Australian, Japanese, and Brazilian market access for its modern medical robotic system. The Medical Device Single Audit Program (MDSAP) that AVRA is employing, is a single inspection that, upon completion, is expected to support market access to the six most important medical device marketplaces.

In September, AVRA Medical Robotics announced it appointed Dr. Vipul Patel to Chair its Medical Advisory Board and Dr. Eytan Pollak to Chair the Scientific Advisory Board, effective immediately. Dr. Vipul Patel is the Founder and Medical Director of the Florida Hospital Global Robotics Institute, Founder and Vice President of the Society of Robotic Surgery, and Founder and Editor Emeritus of The Journal of Robotic Surgery.

Dr. Eytan Pollak received his B.Sc. and M.Sc. from Technion-I.I.T. (Haifa, Israel) and his Ph.D. from Purdue University, West Lafayette, Indiana. He has three decades of experience in managing research and development programs, holds a number of patents, and has published papers in Control Systems, Robotics, Distributed Flight and Ground Simulations/Simulators, Embedded Systems, and Cyber Physical Systems.

AVRA Medical Robotics, Inc. (AVMR), closed Monday's trading session at $1.25, even for the day, on 350 volume with 3 trades. The average volume for the last 3 months is 508 and the stock's 52-week low/high is $1.00/$3.25.

Corvus Gold, Inc. (CORVF)

NetworkNewsWire, Zacks, Stock News Now, Stock Digest, The Daily Gold, MineStat, Street Insider, Investing News, Stockhouse, The Prospector News, GuruFocus, Real Investment Advice, Wallet Investor, Junior Mining Network, Research Pool, InvestorsHub, Trading View, Investors Hangout, and Morningstar reported earlier on Corvus Gold, Inc. (CORVF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, Corvus Gold, Inc. acquires, explores, and develops mineral properties chiefly in the USA. The Company’s mandate is to become a foremost exploration and development enterprise with the ultimate aim of becoming a non-operating gold producer with significant carried interest and royalty exposure. It’s principal mineral property is the North Bullfrog Project. This is a gold-silver mining project in northwestern Nye County, Nevada. Corvus Gold is headquartered in Vancouver, British Columbia.

The North Bullfrog Project comprises leased, patented, and unpatented mining claims encompassing an area of roughly 86.6 km2. These consist of a mix of private mineral leases of patented federal mining claims and 1,057 federal unpatented mining claims. The Project is 10 km north of Beatty, Nevada, and 8 km north of the Bullfrog Mine previously operated by Barrick Gold Corporation.

The North Bullfrog Project is 100 percent controlled by Corvus Gold. It represents a large, low-sulphidation, epithermal bulk-tonnage gold system hosted in volcanic and sedimentary rocks.

Corvus Gold also has its Mother Lode Project. This Project is 165 km northwest of Las Vegas, Nevada, 10 km east of Beatty, Nevada, and approximately 20 road km’s from the Company’s North Bullfrog project in the Walker Land gold belt. The Mother Lode Project consists of 445 federal unpatented mining claims covering an area of around 36.5 km².

Earlier this month, Corvus Gold announced it received initial assay results from its Phase-4 Mother Lode resource expansion drilling program. Both holes returned positive results from the southwest part of the deposit where Main Zone mineralization has now extended to the southwest part of the resource area. Corvus believes that this Southwestern extension of higher-grade mineralization has demonstrated potential for the deposit to continue expansion in multiple directions and now at depth with hole ML19-119 intersecting 50.3m @ 1.50 g/t gold in newly identified intrusive zone.

Mr. Jeffrey Pontius, President and Chief Executive Officer of Corvus Gold, said, “The new Phase-4 results at Mother Lode has begun where we left off earlier this year, by successfully expanding the deposit with thick, higher-grade Main Zone mineralization. Additionally, the discovery of a new deep intrusive related zone is exciting as it may be the first indicator of a significant new gold system below the main Mother Lode deposit as outlined by our new geophysical target.”

Corvus Gold, Inc. (CORVF), closed Monday's trading session at $1.58, up 5.3333%, on 55,879 volume with 117 trades. The average volume for the last 3 months is 33,237 and the stock's 52-week low/high is $1.12999999/$2.13199996.

Future Farm Technologies, Inc. (FFRMF)

Zacks, Investing Daily, Daily Marijuana Observer, Infront Analytics, Marijuana Stocks, TipRanks, MarketBeat, GlobeNewswire, CannabisFN, Macroaxis, Nasdaq, OTC Markets, Barchart, Morningstar, GuruFocus, otc.watch, Dividend Investor, TradingView, Wallet Investor, InvestorsHub, Seeking Alpha, Stockhouse, Dividend.com, Investors Hangout, and MarketWatch reported earlier on Future Farm Technologies, Inc. (FFRMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Future Farm Technologies, Inc. is positioned to be a foremost supplier of hemp-derived CBD (cannabidiol) products to meet the increasing demand in the U.S. and international markets. Its experienced management team has a deep understanding of operations and agriculture with the financial and regulatory expertise needed to become an industry leader in the changing market for CBD and related compounds.

The Company previously went by the name Arcturus Growthstar Technologies, Inc. It changed its corporate name to Future Farm Technologies, Inc. in February of 2017. Its shares trade on the OTC Markets Group’s OTCQB. Future Farm Technologies has offices in Vancouver, British Columbia, and Dedham, Massachusetts.

At present, the Company’s key initiatives are the cultivation and processing of its hemp crop growing in Maine, the pursuit of other hemp-related opportunities across the United States, and the development of elite strains of cannabis in Canada. This past October, Future Farm Technologies announced that hemp from its farm in Hersey, Maine passed the State-mandated testing for acceptable (i.e. below 0.3 percent) levels of THC (Tetrahydrocannabinol).

In November, Future Farm Technologies announced that it completed the drying and curing phase of its crop of hemp and seeds in Maine. Both crops attained yields that outpace Future Farm’s present apparatus for seed extraction, plant bucking, processing and storage.

To address the success of this year’s harvest, Future Farm Technologies is in the process of acquiring stronger seed extraction and cleaning equipment, additional resources for storage and transportation, and larger industrial scales.

Mr. William Gildea, Chief Executive Officer of Future Farm Technologies, said, "These early findings are great news for us and as we look to meet the needs of our robust pipeline of carefully curated and diverse customers, the abundance of product enables us to service the demand for seeds, biomass, oils, extracts and contract manufacturing.”

Future Farm Technologies, Inc. (FFRMF), closed Monday's trading session at $0.02637, up 3.8189%, on 317,257 volume with 63 trades. The average volume for the last 3 months is 212,521 and the stock's 52-week low/high is $0.0252/$0.27000001.

Gold Springs Resource Corp. (GRCAF)

Stockhouse, Trade Ideas, Junior Mining Network, Wallet Investor, Barchart, TMXmoney, Market Screener, Investors Hangout, Nasdaq, Morningstar, InvestorsHub, TradingView, GuruFocus, Dividend Channel, Dividend Investor, MarketWatch, and GlobeNewswire reported beforehand on Gold Springs Resource Corp. (GRCAF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Gold Springs Resource Corp. concentrates on the exploration and expansion of the gold and silver resources at its Gold Springs Project in Nevada and Utah. Gold Springs is situated in the prolific Great Basin of the western United States, in one of the best mining jurisdictions in the world. Company Management has wide-ranging experience in international exploration and the mining industry. The Company previously went by the name TriMetals Mining, Inc. It changed its name to Gold Springs Resource Corp. last month.

Incorporated in 2006, Gold Springs Resource has its corporate office in Vancouver, British Columbia. Last month, the Company reported that starting, November 12, 2019, its common shares commenced trading on the US OTCQB under the new trading symbol GRCAF.

The Company’s belief is that Gold Springs has the potential to host multimillion-ounce gold and silver resources. The Gold Springs Project is 100 percent owned by Gold Springs Resource. The Project straddles eastern Lincoln County, Nevada, and western Iron County, Utah – the above-mentioned Great Basin of western USA). It is an advanced exploration stage gold project and has numerous targets with four resource zones open for expansion.

The Gold Springs Project has shallow open pit, low sulphidation, heap leach potential. It is a district-scale property. It has medium-term potential with drilling for resource upgrade and expansion at the Jumbo Trend and for identification of high-grade mineralization at the new Homestake Target.

The Project encompasses roughly 7,847 hectares. These consist of federal lode claims, Utah State leases, as well as patented mining claims held through leases and purchases. Gold Springs Resource has identified 25 drill-targets based on +1 g/t gold (Au) outcropping samples, geologic and structural modeling, and geophysical results.

Gold Springs Resource has recently recommenced its drill program at its Gold Springs property. Drill results are expected this month and in January of 2020. The Company’s emphasis for 2019 and beyond is on the exploration and expansion of the mineral resources at its Gold Springs Project.

Gold Springs Resource Corp. (GRCAF), closed Monday's trading session at $0.1183, off by 0.504626%, on 1,059 volume with 2 trades. The average volume for the last 3 months is 37,255 and the stock's 52-week low/high is $0.019999999/$0.127100005.

iCoreConnect, Inc. (ICCT)

Penny Stock Base, Market Wire News, EIN Newsdesk, The Online Investor, Street Insider, VentureLine, Stockopedia, Market Screener, Barchart, Wallet Investor, TradingView, Morningstar, Dividend Investor, Seeking Alpha, YCharts, GuruFocus, PitchBook, Simply Wall St, GlobeNewswire, MarketWatch and InvestorsHub reported earlier on iCoreConnect, Inc. (ICCT), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

iCoreConnect, Inc. is a cloud-based software and technology company providing secure communication and healthcare practice management. Fundamentally, iCoreConnect is a national provider of secure communications for high-compliance industries including healthcare, finance and legal. Its software allows organizations and individuals to easily exchange information with 2048-bit encryption in full compliance of present federal laws. The Company previously went by the name iMedicor, Inc. It changed its name to iCoreConnect, Inc. in June of 2017. Established in 2001, iCoreConnect is based in Winter Garden, Florida.

The Company’s product line includes iCoreExchange (HIPAA-Compliant Email Exchange); iCoreDental (Cloud-Based Dental Practice Management System); iCoreMD (Cloud-Based Electronic Health Record (EHR) System); iCoreHuddle (Instant Access to Prescription Drug Monitoring); and iCoreRX (Standalone ePrescription Software). Its product line also includes iCoreCodeGenious (Rapid ICD-10 Coding Tool); iCoreExam (Cloud-Based Intake and Exam EHR); iCoreFlex (Private, Encrypted Association Network); iCoreSecure (2048-bit Secure Encrypted Email); and iCoreLegal (2048-bit Secure Encrypted Email with Time Tracking). Moreover, Allscripts has certified iCoreCodeGenius to help one document any medical condition in 60 seconds.

In August of this year, iCoreConnect announced the latest software update for its award-winning iCoreMD and iCoreDental practice management Electronic Heath Records (EHR) software. The most recent version 2.30 update includes almost 30 function and feature suggestions from its customers. Roughly 2,000 physicians and dentists helped design and develop iCoreDental and iCoreMD practice management EHR software, and also iCoreExchange HIPAA-compliant, secure email.

In November, iCoreConnect announced the selection of iCoreRx as an Endorsed Solution of the North Carolina Dental Society (NCDS). iCoreRx accurately and quickly simplifies electronic prescription writing. North Carolina’s 2017 Strengthen Opioid Misuse Prevention (STOP) Act mandates Electronic Prescribing of Controlled Substances (EPCS). The EPCS mandate takes effect January 1, 2020. iCoreRx meets all EPCS requirements.

iCoreConnect President and Chief Executive Officer, Mr. Robert McDermott, said,, “With a plethora of changes in the laws, providers everywhere are affected. We developed iCoreRx to be the compliant, secure and simple method to ePrescribe.”

iCoreConnect, Inc. (ICCT), closed Monday's trading session at $1.68, off by 6.6667%, on 14,053 volume with 16 trades. The average volume for the last 3 months is 308 and the stock's 52-week low/high is $0.25/$2.00999999.

Cardax, Inc. (CDXI)

Zacks, Street Insider, The Street, 4-Traders, Stockopedia, Morningstar, InvestorsHub, Market Exclusive, MarketWatch, GuruFocus, last10k, Barchart, Stockhouse, and Street Insider reported earlier on Cardax, Inc. (CDXI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cardax, Inc. is a development stage Life Sciences Company listed on the OTCQB. It dedicates primarily all its efforts to developing consumer health and pharmaceutical products that it believes will provide many of the anti-inflammatory benefits of steroids or NSAIDS through targeting many of the same inflammatory pathways and mediators, however with exceptional safety profiles. Cardax has its corporate headquarters in Honolulu, Hawaii.

The Company is preparing proprietary nature-identical products and related derivatives via total synthesis to provide scalable, pure, and economical therapies for diseases where inflammation and oxidative stress are strongly implicated. This includes, but is not limited to, osteoarthritis, rheumatoid arthritis, dyslipidemia, metabolic disease, diabetes, cardiovascular disease, hepatitis, cognitive decline, macular degeneration, and prostate disease.

Cardax’s initial main focus is its astaxanthin technologies. Astaxanthin is a strong and safe, naturally occurring, anti-inflammatory and anti-oxidant without the adverse side effects characteristic of anti-inflammatory treatments using steroids or NSAIDS (including immune system suppression, liver damage, cardiovascular disease risk, and gastrointestinal bleeding).

The Company’s ZanthoSyn® is its first product to help consumers safely address their inflammatory health. Cardax says that ZanthoSyn® is a physician recommended, anti-inflammatory supplement for health and longevity that features astaxanthin with optimal absorption and purity. ZanthoSyn® contains astaxanthin, which is Generally Recognized as Safe (GRAS) according to Food and Drug Administration (FDA) regulations. The safety and efficacy of the Company’s product candidates have not been directly evaluated in clinical trials or confirmed by the FDA.

Previously, Cardax announced it launched its Cardiovascular Health Astaxanthin Supplement Evaluation (CHASE) clinical trial targeting cardiovascular inflammatory health. The first subject was dosed on September 19, 2018. This randomized, double-blind, placebo-controlled CHASE clinical trial will evaluate the effect of low-dose and high-dose ZanthoSyn® on cardiovascular health, as measured by C-Reactive Protein (CRP) levels, over 12 weeks in up to 360 subjects with documented cardiovascular risk factors. Additionally, the study will include an optional open label extension through 48 weeks.

In December 2018, Cardax and GNC announced that they are expanding the sales and marketing program for ZanthoSyn®. GNC is the exclusive brick-and-mortar retail channel for ZanthoSyn®. GNC will augment Cardax's sales and marketing efforts with additional initiatives to boost ZanthoSyn® product awareness and education among GNC store associates and customers nationwide.

Cardax, Inc. (CDXI), closed Monday's trading session at $0.065, up 30.00%, on 7,700 volume with 5 trades. The average volume for the last 3 months is 49,690 and the stock's 52-week low/high is $0.032000001/$0.25.

BioVie, Inc. (BIVI)

NetworkNewsWire, Penny Stock Tweets, Stockhouse, Investor Place, Wallmine, Wealth Insider Alert, InvestorsHub, Morningstar, YCharts, EuroInvestor, MarketWatch, GuruFocus, Street Insider, and Simply Wall St reported earlier on BioVie, Inc. (BIVI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioVie, Inc. focuses on the discovery, development, and commercialization of unique drug therapies for liver disease. At present,  the clinical-stage Company is centering on commercializing BIV201. This is a novel approach to the treatment of ascites due to chronic liver cirrhosis. OTCQB-listed, BioVie has its corporate headquarters in Beverly, Massachusetts.

The Company states that BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, NASH, and alcoholism. The US Patent and Trademark Office (USPTO) issued US Patent No. 9,655,945 covering BioVie’s new drug candidate BIV201. 

BIV201 has Orphan Drug designation for the most common of these complications, ascites, which represents a major unmet medical need. The Food and Drug Administration (FDA) has never approved any drug specifically for treating ascites.

BIV201 is a continuous infusion of the peptide terlipressin, first undergoing development for the treatment of refractory ascites. Terlipressin, dosed differently, is approved in about 40 nations for other complications of liver cirrhosis coming up from a similar disease pathway. Terlipressin is not available in the United States.

BioVie announced in April 2017 that it received notice from the FDA that the planned Phase 2a clinical trial of its new drug candidate BIV201 could begin. This was based on BioVie’s IND to conduct a study in patients with refractory or intractable ascites due to advanced liver cirrhosis. BioVie also announced in April 2017 the signing of a Cooperative Research and Development Agreement (CRADA). This is to conduct a Phase 2a clinical trial of BIV201 in patients with refractory or intractable ascites because of advanced liver cirrhosis.

The FDA has granted Fast Track designation for BIV201 (continuous infusion terlipressin), BioVie’s patented Orphan drug candidate. BIV201 is currently undergoing evaluation for the treatment of refractory ascites because of liver cirrhosis in a mid-stage (Phase 2a) U.S. clinical trial.

The FDA has granted Orphan Drug designation to BioVie for terlipressin for the treatment of hepatorenal syndrome (HRS). BioVie earlier secured an Orphan Drug designation for terlipressin for treating ascites. The Company is exploring additional Orphan designation opportunities.

Recently, BioVie announced that it completed enrollment in a Phase 2a open-label clinical study of BIV201 (continuous infusion terlipressin) in patients with refractory ascites because of advanced liver cirrhosis.

Patrick Yeramian, MD, BioVie’s Chief Medical Officer, said, “We are pleased to have achieved this important clinical milestone as we continue to develop BIV201 for patients with refractory ascites who are at high risk of deadly complications. What we have learned from this initial study is informing our next clinical trial design. The results will be presented to the FDA in the first half of 2019 and we expect to receive guidance on the BIV201 clinical development plan.”

BioVie, Inc. (BIVI), closed Monday's trading session at $0.053, even for the day, on 6,500 volume. The average volume for the last 3 months is 1,363 and the stock's 52-week low/high is $4.375/$7.39375019.

International Frontier Resources Corporation (IFRTF)

Connecting Investor, YCharts, Wallet Investor, GuruFocus, 4-Traders, MarketWatch, Stockhouse, Marketwired, Otc.Watch, Investment Pitch, Investors Hub, Investing News, Market Screener, and Emerging Growth reported earlier on International Frontier Resources Corporation (IFRTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.  

International Frontier Resources Corporation has a demonstrated track record of advancing oil and gas projects. The OTCQB-listed Company, by way of its Mexican subsidiary, Petro Frontera S.A.P.I de CV and strategic joint ventures (JVs) is advancing the development of petroleum and natural gas assets in Mexico.  International Frontier Resources is based in Calgary, Alberta.

International Frontier Resources (IFR) also has projects in the U.S. and Canada. This includes the State of Montana and the Northwest Territories. IFR created a JV company in 2015 - Tonalli Energia - together with Grupo Idesa, one of Mexico’s largest petrochemical companies.  Grupo Idesa is a well-established Mexican petrochemical company.

Block 24 Tecolutla establishes IFR’s Mexican JV as one of the first operators’ in Mexico. In addition, it provides important insights into future rounds. Tecolutla is a very underdeveloped mature field with considerable upside potential.  The Tecolutla Block is in the Tampico-Misantla Basin within the State of Veracruz.

The Tecolutla Field is 7.2 square kilometers. It contains an oil reservoir at 2,340 meters or around 7,700 feet. The Tecolutla Block is a 60-80 m gross pay carbonate reservoir on a structural high with proven oil production.

Tonalli has submitted the regulatory applications and documentation that will allow IFR to go ahead with the drilling permit and operations at Tecolutla. The expectation is that the existing wells at Tecolutla will exceed historic production numbers and peak initial production (IP) rates with the arrival of new recovering techniques, technology, and expertise to be undertaken by Tonalli.

This past November, International Frontier Resources Corporation (IFR) announced that Tonalli Energia, IFR’s JV with Mexican petrochemical leader Grupo IDESA, spudded the first conventional horizontal well, (TEC-11), at its onshore Tecolutla block. TEC-11 is the initial horizontal well in a potential multi-well plan to develop the northern extension of the Tecolutla field that has been identified on Tonalli’s interpretation of the 3D seismic.

Moreover, in December, IFR announced that Tonalli Energia reached total depth at its first conventional horizontal well, (TEC-11), on its onshore Tecolutla block. The TEC-11 field development horizontal well was drilled to a depth of 3283 meters (m) Measured Depth (MD). A total of roughly 670m of measured length of Cretaceous limestone was drilled before the total depth was reached. Oil shows were encountered during drilling.

Furthermore, Tonalli received its first payment from PEMEX for oil shipped from its Tecolutla field. Tonalli’s TEC-10 producing well averaged 156 barrels of oil per day in October and November at an approximate average crude sales price of USD$64.73 per barrel.

International Frontier Resources Corporation (IFRTF), closed Monday's trading session at $0.0099, up 54.6875%, on 27,700 volume with 5 trades. The average volume for the last 3 months is 9,800 and the stock's 52-week low/high is $0.006/$0.090999998.

Telkonet, Inc. (TKOI)

SmallCapVoice, RedChip, FeedBlitz, Alternative Energy, Stock News Now, CoolPennyStocks, BullRally, Stock Rich, and HotOTC reported previously on Telkonet, Inc. (TKOI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Telkonet, Inc. provides unique intelligent automation platforms at the vanguard of the Internet of Things (IoT) space. The Company helps commercial audiences better manage operational costs via its EcoSmart intelligent automation platform. Vertical markets that benefit from EcoSmart products include hospitality, education, military, government, healthcare and multiple dwelling housing. Telkonet has its corporate headquarters in Waukesha, Wisconsin.

Telkonet’s EcoSmart intelligent automation platform is supported by a full-suite of IoT-connected devices. These devices provide in-depth energy usage information and analysis. This allows building operators to cut energy expenses. The Company has successfully deployed more than 600,000 devices across greater than 3,000 properties.

The foundation of Telkonet’s EcoSmart platform is on four distinct pillars. One pillar is the EcoSmart suite of IoT products - connected devices. A second is EcoCentral – the Company’s cloud-based EMS dashboard. The third pillar is EcoSmart Mobile – Telkonet’s smart device app. The fourth pillar is EcoCare - its service and support subscription. The Company’s platform integrates with a broad spectrum of products serving varied markets.

This past March, Telkonet announced that it, and reseller partner, Legend Energy Advisors, deployed Telkonet's innovative EcoSmart energy-management platform at Murray Hill Marquis in New York, New York, with EcoSmart Mobile application control. EcoSmart Mobile gives tenants easy control of their apartment's comfort. This is while providing the property major opportunities for energy savings.

EcoSmart takes advantage of occupancy-sensing thermostats, stand-alone sensors, plugs, light switches, and top third-party integrations and automation, to intelligently control energy utilization and create immersive user experiences.

Recently, Telkonet announced it has teamed with Volara, the first voice-based hotel guest engagement solution, which turns voice into a strong hospitality business tool. Together, they now offer a hospitality environment in which guests can use voice commands to control intelligent in-room devices and platforms to set scenes within their own hotel rooms. These scenes can incorporate one device or numerous different devices to create the exact environment that a hotel guest requests.

Hotel operators can configure ‘scenes’ and ‘commands’, which will enable guests to select their comfort level and environment. These settings will be customized to the EcoSmart Platform devices deployed and the capabilities provided within the hotel.

Telkonet, Inc. (TKOI), closed Monday's trading session at $0.065, up 21.7228%, on 214,200 volume with 31 trades. The average volume for the last 3 months is 76,200 and the stock's 52-week low/high is $0.05/$0.159799993.

FalconStor Software, Inc. (FALC)

StockTwits, Simply Wall St, StreetInsider, Insider Financial, The Street, OTC Markets, Zacks, YCharts, and Business Insider reported on FalconStor Software, Inc. (FALC), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, FalconStor Software, Inc. is a market leader in storage software. The Company offers a converged data services software platform that is hardware agnostic. Its open, integrated flagship solution is FreeStor®. This solution lessens vendor lock-in and gives enterprises the freedom to select the applications and hardware components, which make the best sense for their business.

Established in 2000, FalconStor Software has its head office in Austin, Texas. The Company also has offices in Melville, New York, and throughout Europe and the Asia Pacific region.

FalconStor incorporated in Delaware as Network Peripherals, Inc., in 1994. Pursuant to a merger with FalconStor, Inc., in 2001, the previous business of Network Peripherals, Inc. was discontinued. The newly re-named FalconStor Software, Inc. continued the storage software business started in 2000 by FalconStor, Inc.

The Company gives customers the ability to move workloads to the right destination, on-premise or in the cloud. Its FreeStor® offers a true software-defined storage solution with intelligence and built-in analytics. FreeStor® helps lower the cost of storage hardware, modernize existing infrastructure, and helps a business take back control with interoperability, Core-to-Edge insight, and single-pane-of-glass management and monitoring.

FalconStor Software’s corporate mission is to maximize data availability and system uptime to ensure nonstop business productivity. This is while simplifying data management to lessen operational costs.

Recently, FalconStor Software announced financial results for its Q4 and fiscal year ended December 31, 2017. For the three months ended December 31, 2017, the Company delivered Net GAAP (Generally Accepted Accounting Principles) Operating Income of $1.4 million on Revenues of $6.3 million.

For the twelve months ended December 31, 2017, FalconStor delivered GAAP Net Operating Income of $1.0 million versus a Net Operating Loss of $10.3 million for the same period the year prior.

Mr. Todd Brooks, FalconStor Software’s Chief Executive Officer, stated, “Q4 continues the return to profitability first delivered in Q3 2017, and powered the company to an annual profit for 2017, the first since 2008. This performance further demonstrates the stability our strategic restructuring is creating.”

Recently, FalconStor Software announced the appointment of Mr. Brad Wolfe as Chief Financial Officer (CFO), effective April 9, 2018. In association with the appointment, Pat McClain, the Company’s previous CFO, transitions into a senior advisor role in continued support of FalconStor’s strategic plan execution.

Mr. Wolfe has more than three decades of finance and operations experience. This includes wide-ranging growth-focused leadership within public and private equity, and also M&A (Mergers and Acquisitions), most recently serving as CFO for Asure Software (ASUR).

FalconStor Software, Inc. (FALC), closed Monday's trading session at $3.95, up 45.7565%, on 753 volume with 12 trades. The average volume for the last 3 months is 189 and the stock's 52-week low/high is $2.36999988/$17.00.

Blow & Drive Interlock Corp. (BDIC)

MarketWatch, YCharts, TradingView, Equities.com, and News to Watch reported on Blow & Drive Interlock Corp. (BDIC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Blow & Drive Interlock Corp. provides automotive and criminal offender monitoring security products. The Company has its state-of-the-art ignition interlock device, the BDI-747. The device is approved and available in eight states for evidentiary and preliminary screening use. In essence, Blow & Drive Interlock is an offender monitoring and police-grade alcohol detection device manufacturing and offender monitoring business.  Blow & Drive Interlock is based in Los Angeles, California. 

Interlocks are required for use by DUI or DWI (Driving Under The Influence or Driving While Intoxicated) offenders. This is as part of their mandatory court or motor vehicle department program. The Company’s aim  is to have the BDI-747 available to customers across the U.S.

In addition, Blow & Drive Interlock continues to do research and development (R&D) on the next stage of offender monitoring. The Company believes this will be Smartphone enabled monitoring applications, which could reduce or eliminate  the requirement for ankle bracelets or hand-held breathalyzers.  

The BDI-747 is an ignition interlock device, breath-alcohol testing device about the size of a Smartphone. The ignition interlock device requires the driver to exhale into the device prior to starting the vehicle. The device will prevent the vehicle from starting if the driver's blood-alcohol content exceeds a predetermined set level. 

The BDI-747 can record BAC levels. It provides 2-way communication, GPS location technology, and image technology. Moreover,  the BDI-747 is wireless.

One of Blow & Drive Interlock’s new products is its Home Alcohol Monitoring Device. This handheld device has a camera and GPS/WIFI & live streaming. It enables those in Judicial and Probation departments to monitor offenders who are required to stay sober from alcohol while on probation.

The Company also has its 4G LTE Live-Streaming Video Body Worn Camera for Law Enforcement. With the 4G LTE Live-Streaming Video Body Worn Camera, Law Enforcement Personnel on the scene can transmit a live feed from their body cameras to headquarters. This allows police decision makers’ access to real time information regarding what each officer is seeing.

The body camera weighs roughly 210g. It provides up to 32 GB of memory and 5-megapixel recording.

Recently, Blow & Drive Interlock introduced BADGECAM. This is a body worn camera akin to the models law enforcement officers use but to protect anyone at anytime. The BADGECAM can be heavily incorporated by Human Resources (HR) departments, security personnel, counter staff, or any other jobs that come with a potential confrontation.

The intention of BADGECAM is to become a vital preventative measure against workplace violence, discrimination, or personal/sexual harassment. With BADGECAM, one can immediately begin recording up to 6 hours of high quality video and audio with a single pull.

The design of BADGECAM is to be affixed to any article of clothing. Blow & Drive Interlock plans to launch the BADGECAM between Q2 and Q3 of 2018.

Blow & Drive Interlock Corp. (BDIC), closed Monday's trading session at $0.054, up 28.5714%, on 6,501 volume with 4 trades. The average volume for the last 3 months is 15,440 and the stock's 52-week low/high is $0.019999999/$0.100000001.

MamaMancini's Holdings, Inc. (MMMB)

TheMicrocapNews, TaglichBrothers, Stock News Now, SmallCapVoice, Marketbeat.com, and OTC Markets Group reported earlier on MamaMancini's Holdings, Inc. (MMMB), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

MamaMancini's Holdings, Inc. is a marketer of specialty pre-prepared, frozen, and refrigerated all natural food products (as defined by the United States Department of Agriculture - USDA). The Company is a marketer and distributor of a line of beef meatballs and turkey meatballs all with sauce, five cheese stuffed beef and turkey meatballs all with sauce, original beef and turkey meatloaves, chicken parmesan, stuffed peppers, and other like Italian cuisine products. MamaMancini’s Holdings is headquartered in East Rutherford, New Jersey.

MamaMancini's distribution channel includes major retailers and distributors, including Costco, Publix, Shop Rite, Jewel, Save Mart, Lucky's, Lunds and Byerlys, SuperValu, Safeway, Albertsons, SpartanNash, Bashas, Whole Foods Market, Hy-Vee, Sam's Club, and Shaw's. Major retailers and distributors also include Kings, Roche Bros., Key Foods, Stop & Shop, Giant, Giant Eagle, Foodtown, Kroger, Shoppers, King Kullen, Lowes, Central Market, Weis Markets, Ingles, Food City, The Fresh Market, Sysco, Burris Foods, C&S, and Driscoll Foods.

In addition, the Company sells an assortment of its products on air and online on QVC, which is the world's largest direct to consumer marketer.

MamaMancini's offers Slow Cooked Italian Sauce and Meatballs, Stuffed Meatballs, Slow Cooked Sauces, Slow Cooked "Italian Style Sauce" and Meatballs - Gluten Free, Slow Cooked Italian Sauce and Meatballs made without Antibiotics, bacon gorgonzola beef meatloaf, and its Italian Style Meatloaf. It also has Food Service offerings and offers Bulk Deli Orders.

In August, MamaMancini's Holdings announced that it signed a Letter of Intent (LOI) to acquire Joseph Epstein Food Enterprises, Inc. (JEFE), a manufacturer of food products, which has been the sole manufacturer of MamaMancini’s products since inception. Under the agreed terms, no cash would be exchanged between the parties. JEFE is currently owned by the Chief Executive Officer and President of MamaMancini's Holdings, who in total owns roughly 44 percent of the Company's common stock.

Recently, MamaMancini's Holdings announced financial results for Q2 of fiscal year 2018, ended July 30, 2017. Q2 of fiscal year 2018 Revenue increased 69 percent to $7.0 million versus $4.1 million in the previous year period. Net Income for the second quarter was $24,000 in comparison to a Net Loss of $(277,000) in the previous year period. This represents a $301,000 improvement.

Net Loss available to common stockholders was $(5,000), or $0.00 per diluted share, during Q2 of fiscal 2018, versus a Net Loss of $(324,000), or $(0.01) per diluted share in the same quarter the year prior.

MamaMancini's Holdings also recently announced that its Beef and Turkey Stuffed Meatballs were voted by the QVC Shopping Network audience as the #1 product in the 'Quick and Easy Meals' category during QVC's 2017 Audience Choice Awards Program, yesterday September 13, 2017.

MamaMancini's Holdings, Inc.  (MMMB), closed Monday's trading session at $1.16, up 30.3517%, on 238,759 volume with 194 trades. The average volume for the last 3 months is 38,428 and the stock's 52-week low/high is $0.330000013/$1.25.

The QualityStocks Company Corner

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology Inc. (NASDAQ: POAI), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has revealed that several parties have indicated interest in the potential acquisition of Skyline Medical, the division of the company that produces and sells the STREAMWAY System (http://nnw.fm/u9Acn). The patented, FDA-approved STREAMWAY System is the first truly continuous, direct-to-drain fluid disposal system designed specifically for medical applications.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Monday's trading session at $3.05, up 6.0464%, on 53,595 volume with 239 trades. The average volume for the last 3 months is 40,907 and the stock's 52-week low/high is $2.3499999/$8.50.

Recent News

Green Hygienics Holdings Inc. (OTC: GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (OTCQB: GRYN) was featured today in the 420 with CNW by CannabisNewsWire. During a radio interview on Monday, Cynthia Seivwright, the director of the Department of Health’s Alcohol and Drug Abuse Program in Vermont, said that compared to the current policy, public health would be better protected by regulating marijuana commerce in the state.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for the purpose of extracting cannabidiol (CBD). With more than 25 years of experience in agricultural science and innovation, Green Hygienics aims to become one of the largest providers of industrial hemp-derived CBD products on the planet.

Green Hygienics’ business model includes generating revenues from the sale of hemp and premium-grade CBD products, creating trusted global consumer brands, developing valuable intellectual property (IP) and growing rapidly through strategic acquisitions. With direct regard to acquisitions, the company acts as a business accelerator and a vertical integrator supporting rapid growth and development of companies with extraordinary potential.

Innovation – the Future of Commercial Cultivation

The greatest challenge of the cannabis industry is determining how to deliver a safe and premium-quality product on a consistent basis; antiquated production methods are riddled with recalls and are unsafe from a cultivation production standpoint. Green Hygienics’ solution is to employ scientific methodology combined with sustainable farm practices to achieve optimal soil refinement. The company’s objectives are to produce higher yields and a superior product on a consistent basis to always remain compliant through diligent testing. A secure, premium-quality supply chain is the foundation for the company’s operations.

Green Hygienics’ cultivation approach is based on scientific measurements and data analysis, which transform the cultivation environment into a laboratory environment to deliver superior product.

State-of-the-Art Processing

Processing hemp to produce the finest-quality CBD is a complex, multistage process that should be performed with adherence to the highest standards. Once harvested, the hemp must be carefully handled, dried and stored to prepare it for CBD extraction. Each and every step must be given full care and attention. Green Hygienics’ ambition is to create state-of-the-art infrastructure, employ the latest large-scale processing technologies and adhere to strict quality management systems.

The company strives to constantly develop innovations in industrial hemp for CBD cultivation and to create solutions that lower costs, deliver higher yields and address the challenges of large-scale production.

Brand Development, Marketing and Direct Sales

One of the core drivers of the Green Hygienics business model is to develop or acquire unique brands with global distribution potential. The company sees the market becoming increasingly competitive, and establishing Green Hygienics’ own distinct, trusted brands will be important. By controlling its own supply chain, the company can also leverage strategic advantages in the marketplace, such as the ability to deliver a “best in class” product on a consistent basis. Successful branding is demonstrated by a positive response to a company’s customer service, reputation and products, and Green Hygienics Holdings is acutely aware of the value in this.

Ahead of the Curve

The clear competitive advantage Green Hygienics holds over industry peers is cultivating premium product within the upper-scale product category more efficiently than anyone else in the industry. Currently, the average-size hemp farm in North America is 9 acres. Green Hygienics addresses the challenge of scalability through its farming methodology.

The company’s objective is to produce a higher quality of product at a lower cost and to deliver the finest-quality product to consumers without exception.

In today’s market, inefficient companies and those that produce an inferior product will become vulnerable or disappear, adding considerable value to companies like Green Hygienics that efficiently innovate and operate. The premium cannabis market will continue to achieve higher pricing, and the demand will stabilize. At the end of the day, successful branding backed by superior product will cause companies like Green Hygienics to rise above the competition.

Outlook

Companies within the cannabis sector, states and lawmakers are still figuring out how legislation, consumer demand and innovations will shape the industry. As a safeguard and for long-term resilience, Green Hygienics is preparing for the next plateau with proprietary cultivation and processing systems and tightly controlled growth environments that enable containment of production costs, delivery of higher yields and production of a premium product. These margins will provide the company with a strategic advantage within an increasingly competitive marketplace.

Green Hygienics is constantly studying the market dynamics in North America and abroad and anticipates that both the domestic and international markets will appreciate and be willing to pay a premium to those companies that can deliver best-in-class products.

In line with this expectation, the company’s additional objectives are to secure investment, enhance its balance sheet and increase its value through profitable operations as well as through acquiring and owning the real estate or land it builds upon. Over the long term, this will help Green Hygienics grow in value, provide leverage for rapid expansion and offer security for investors. The company will be positioned to capitalize on any opportunity within the industry or to acquire distressed assets, which is part of its growth strategy.

Green Hygienics plans to establish lead brands starting in the California market, to secure trademarks, and to develop and secure intellectual property assets with regard to cultivation and processing.

Green Hygienics Holdings Inc. (GRYN), closed Monday's trading session at $2.05, up 6.7708%, on 1,436 volume with 4 trades. The average volume for the last 3 months is 11,673 and the stock's 52-week low/high is $0.100100003/$2.48000001.

Recent News

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was also featured today in the 420 with CNW by CannabisNewsWire.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Monday's trading session at $1.30, up 4.9435%, on 45,237 volume with 68 trades. The average volume for the last 3 months is 51,207 and the stock's 52-week low/high is $1.08749997/$6.00810003.

Recent News

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a developer and provider of cellular communications solutions for enterprise workers and first responders, today announced its receipt of two purchase orders totaling over $900,000 for its connected vehicle and Push-to-talk over Cellular (“PoC”) solutions. To view the full press release, visit http://nnw.fm/fV3iK.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Monday's trading session at $0.2528, up 3.6066%, on 90,176 volume with 31 trades. The average volume for the last 3 months is 87,286 and the stock's 52-week low/high is $0.198500007/$0.446249991.

Recent News

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), a fully integrated oil company focused on the development and implementation of its new proprietary technology for oil extraction with producing assets at Asphalt Ridge near Vernal Utah, today announced that, since last reported, it has increased its daily average oil production and made changes to its facility’s oil quality baseline. To view the full press release, visit http://nnw.fm/fMa0U

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Monday's trading session at $0.173, up 13.5171%, on 220,424 volume with 52 trades. The average volume for the last 3 months is 288,368 and the stock's 52-week low/high is $0.112099997/$0.51999998.

Recent News

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) was featured today in a publication from CBDWire, examining how if you have been paying even the slightest attention to the news for the past few years, you have undoubtedly heard of cannabidiol (CBD), the hemp extract that has taken the world by storm. For a product that was barely known 5 years ago, it has come a long way, with a market estimated to be worth billions.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed Monday's trading session at $0.1547, up 1.3098%, on 106,656 volume with 54 trades. The average volume for the last 3 months is 125,918 and the stock's 52-week low/high is $0.150000005/$0.930000007.

Recent News

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Business-to-business pharmacy services supplier Trxade Group Inc. (OTCQB: TRXD)has remained consistently profitable over the last couple of years, reporting seven consecutive quarters of revenue growth, as it continues to expand its services and reach more patients nationwide, CEO Suren Ajjarapu said in a recent interview with NetworkNewsWire (http://nnw.fm/uCMu0).

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed Monday's trading session at $1.25, even for the day, on 9,002 volume with 5 trades. The average volume for the last 3 months is 3,565 and the stock's 52-week low/high is $0.230000004/$1.60000002.

Recent News

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF).

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) was featured today in a publication from HempWireNews, examining how, according to new estimates by the United States Department of Agriculture (USDA), hemp sales in the U.S. could increase to $25 million by 2020. USDA also estimated that by 2022, the sales could skyrocket to $100 million.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (OTCQB: HTPRF), closed Monday's trading session at $0.1537, even for the day, on 250 volume. The average volume for the last 3 months is 4,496 and the stock's 52-week low/high is $0.07/$0.920000016.

Recent News

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was highlighted today in a publication from Motley Fool, examining how, although Organigram might not be the most talked-about marijuana stock in 2020, it could be the best performer in its industry thanks to ultra-low costs of production. That makes it the better buy right now, but tread lightly and watch for signs the company can keep meeting production goals as more retail outlets come online.

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Monday's trading session at $2.56, off by 1.1583%, on 2,175,942 volume with 6,528 trades. The average volume for the last 3 months is 2,476,709 and the stock's 52-week low/high is $2.00/$8.43999958.

Recent News

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings (OTC: MCTC)today provided a letter to its shareholders to recap 2019 and provide an overview of the company’s plans moving into 2020. Among the topics covered, the letter discussed the company’s reorganization with a new management team led by Arman Tabatabaei, as well as installation of an experienced board of directors. To view the full press release, visit http://cnw.fm/GS7rw. Also today, the company was highlighted in a publication from CBDWire, examining how MCTC is expanding its research beyond the four patents the company has developed with the aim of establishing novel applications of polymeric nanoparticles of cannabinol (CBN) and cannabinoid glycosides.

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Monday's trading session at $0.36, off by 7.6923%, on 20,359 volume with 19 trades. The average volume for the last 3 months is 12,783 and the stock's 52-week low/high is $0.075000002/$3.00.

Recent News

OriginClear (OTC: OCLN)

The QualityStocks Daily Newsletter would like to spotlight OriginClear (OTC: OCLN).

OriginClear Inc. (OTC: OCLN), a leading provider of water-treatment solutions, and Depuporc S.L., the company’s Spain-based licensee (http://nnw.fm/ktM6g), have partnered to build a comprehensive water-treatment system that continuously transforms pig manure into a zero-waste output of fertilizer and clean irrigation water (http://nnw.fm/1dM01). The system could be transformative in the country, which is the world’s fourth-highest pork producer, positioning OCLN for significant market penetration.

OriginClear (OTC: OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.


Industrial Pretreatment Waste Water Treatment Plant (WWTP) designed by Daniel M. Early, using reinforced thermoplastic modules.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear’s water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

Product Portfolio

OriginClear groups its products into three main categories:

  1. Water Treatment: achieving high grade purification.
  2. Water Conveyance: water transportation and pumping.
  3. Advanced Technologies: commercialization of innovative technologies.

OriginClear’s complete line of compact, on-site, point-of-use products include: advanced purification systems that are skid, rack-mounted and containerized for reverse osmosis, ultrafiltration, media filtration, disinfection, water softening, ion exchange and electrodeionization (EDI), combined as needed in small to medium commercial and industrial applications, and custom-build projects. Water conveyance products include pump and lifting stations, modular storage tanks, and control monitoring panels.

OriginClear’s line of modular water products and systems is key to the self-reliant water treatment revolution as they create “instant infrastructure” – fully engineered, prefabricated and prepackaged systems that use durable, sophisticated materials. The units are available in standard capacities for onsite closed-loop systems at commercial business locations.

The company’s rugged wastewater treatment plants, highly reliable pump stations, and premium water purification units typically offer 25 percent lower initial costs over conventional systems, with greater quality and full connectivity. These pump stations and wastewater treatment products utilize high density thermo-plastics (HDPE) and proprietary, innovative prefabrication methods and materials that deliver the longest life and strongest products.

Breakthrough Technologies

OriginClear has a long history of innovation through its OriginClear Technologies division, which is responsible for identifying leading-edge technologies to solve today’s toughest challenges. These advanced technologies are the centerpiece of the division’s international licensee network. The technologies are developed in OriginClear Technologies, and licensees integrate them into their own products.

Electro Water Separation™ (EWS) and Advanced Oxidation (AOx™) are the principal, well-proven technologies.

EWS is OriginClear’s breakthrough water cleanup technology which utilizes a catalytic process to concentrate and eliminate suspended solids in the worst commercial and industrial wastewater.

AOx is OriginClear’s proprietary advanced oxidation technology which generates a dense cloud of ozone, hydrogen peroxide and hydroxyl radicals, dramatically reducing or eliminating dissolved organic microtoxins, including bacteria and viruses, hormones, drugs, pesticides such as Roundup, and synthetics. AOx has also been shown to effectively reduce harmful chemicals such as ammonia and hydrogen sulfide – the “rotten egg” smell in crude oil that reduces its value.

Through international licensing and partnerships, OriginClear’s advanced technologies are being adopted to treat tough water problems in East and South Asia, Europe and the Middle East, and North America.

Market Opportunity

In just 10 years, the global water services market has doubled into a trillion-dollar industry, driven by improper sanitation and water scarcity. Only 20 percent of all sewage and only 30 percent of all industrial waste are ever treated. Additionally, water leakage results in the loss of 35 percent of all clean water across the planet; reducing that percentage by half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

The statistics demonstrate that we can no longer rely on the efficiencies of giant, centralized water utilities to meet these challenges. An increasing number of businesses are starting to take notice, instead conducting their own water treatment and recycling. Whether by choice or out of necessity, those businesses that do invest in onsite water systems get a tangible asset on their business and real estate, and can enjoy better water quality at a lower cost.

Out of the public’s eye and with OriginClear’s help, a growing number of self-reliant businesses are building Decentralized Water Wealth™ for themselves while also helping their community. They know that environmental, social and governance (ESG) investing guidelines, which represent $22 trillion of assets under management around the world, specifically note the key indicator of how well corporations manage their water.


10,000 Gallon per Day Industrial Membrane Bioreactor Waste Water Treatment Plant designed by Daniel M. Early, PE, using long-lived Structural Reinforced ThermoPlastic (SRTP)

OriginClear is a key enabler of ESG water management for corporations that are increasingly responsible for what was once delegated to central utilities. For example, when a corporation manages its own water, and uses OriginClear’s proprietary hybrid treatment methods, it can significantly reduce both water use and nutrient footprints (carbon, nitrogen, and phosphorus) in one compact package.

These hybrid processes feature advanced blackwater treatment with advanced clean water processing. They can convert toxic nutrients to less harmful compounds, and even capture them for beneficial reuse purposes, as shown in OriginClear’s recent case study.

Revenue Growth through Synergy

Since OriginClear acquired it in 2015, Progressive Water Treatment has generated steady revenues in the range of a million dollars a quarter. It is now the Fabrication and Manufacturing Division for the whole company. The team at Modular Water Systems, headed by Chief Engineer Daniel M. Early, is responsible for overall design and high-level engineering. It relies on the Fabrication and Manufacturing Division to add incremental revenue for its modular product line, without requiring large increases in personnel.

OriginClear believes that these two business units can develop growing revenues through synergy and ultimately help achieve overall profitability. OriginClear also seeks to acquire profitable water companies that can complement the synergy of its existing units and accelerate both revenues and profitability. However, acquisitions are neither guaranteed, nor essential to OriginClear’s continued growth.

 

Leadership

OriginClear’s management team brings strong leadership and a background in managing business operations, sales, technologies, and finance. The team combines idealism with solid commercial skills, achieving a triple bottom line of environmental, social and financial gain.

Riggs Eckelberry – Chairman, CEO and Co-founder
Riggs Eckelberry is a veteran technology manager who led companies to multiple exits during the high-tech boom of the 90s and early 2000s. Eckelberry came to the water industry from a quarter century in high technology, specializing in commercializing breakthrough technologies. During the dotcom boom, he worked on a series of tech successes, such as Quarterdeck’s CleanSweep; security software vendor Panda Software; and the sale of companies to EarthWeb, BeFree, and BellSouth. Just prior to founding what is now OriginClear, he helped drive security software company CyberDefender to an IPO on the Nasdaq as its president and chief operating officer.

Thomas Marchesello – Chief Operating Officer
Thomas Marchesello is a business operations and technology executive with over 20 years’ experience in manufacturing and distribution of products and services. He has 12 years in private equity M&A, doing buyside acquisitions of small to midsize corporations. He has over 10 years advising innovative corporations on ESG strategy and speaks often about industry trends. He began his career in the U.S. Air Force, Space Command Headquarters for environmental sciences. He has held key roles for Fortune 500 companies such as Sony, Thompson Reuters, Morgan Stanley, and Chicago Mercantile Exchange.

Daniel M. Early, PE – Senior Engineer
For the past 25 years, Dan Early has worked as an engineered products development specialist with very strong understanding of the complex and interconnected disciplines, economies, and governmental regulation needed to develop and sustain modern civil infrastructure systems that reflect a balance of environmental stewardship, social expectations, and cultural requirements. Since 2010, Early has specialized in the research, development, and deployment of next generation water infrastructure technologies using heavy plastic manufacturing. His initiatives and innovations anchor Modular Water Systems’ product line.

Marc Stevens – Director of Fabrication and Manufacturing
Marc Stevens brings nearly 40 years of experience to OriginClear’s manufacturing team. His experience in mechanical design, equipment fabrication, installation and a wide range of projects led to his founding what is now OriginClear’s Fabrication and Manufacturing Division. He supervises the design, building and installation of customized, large-scale water treatment systems, including purification technologies for process waters for boilers and cooling towers, drinking water and various industrial waste water applications. Stevens leads the team that also manufactures OriginClear’s standardized Modular Water Systems.

OriginClear (OCLN), closed Monday's trading session at $0.31, off by 6.0606%, on 159,193 volume with 47 trades. The average volume for the last 3 months is 32,386 and the stock's 52-week low/high is $0.100000001/$5.80000019.

Recent News

Grapefruit Boulevard Investments Inc. (IGNG)

The QualityStocks Daily Newsletter would like to spotlight Grapefruit Boulevard Investments Inc., the wholly owned subsidiary of Imaging3 Inc. (IGNG).

Grapefruit Boulevard Investments, a Los Angeles based California corporation and wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG), (collectively “Grapefruit”), this morning announced that, as of today, December 16, 2019, it has filed with the Financial Industry Regulatory Authority (“FINRA”) to change the company’s corporate name to Grapefruit USA, Inc., and stock ticker symbol to “GUSA,” “GPRE,” “GPFT” or such other symbol as FINRA and Grapefruit may agree. To view the full press release, visit http://cnw.fm/h8I9t. Also today, the company was highlighted in a publication from CBDWire, examining how, if you have been paying even the slightest attention to the news for the past few years, you have undoubtedly heard of cannabidiol (CBD), the hemp extract that has taken the world by storm. For a product that was barely known 5 years ago, it has come a long way, with a market estimated to be worth billions.

Grapefruit Boulevard Investments Inc., a California corporation (“Grapefruit”), as of May 31, 2019, is a wholly owned subsidiary of Imaging3 Inc. (OTC: IGNG), a Delaware corporation whose shares of $.001 par value common stock are publicly traded on the OTCMarkets OTCQB Market under the symbol “IGNG.” IGNG is subject to the reporting requirements of the Securities Exchange Act of 1934 and files annual and quarterly reports pursuant thereto. Grapefruit holds licenses originally issued by the State of California in January 2018 to both manufacture and distribute cannabis products. Grapefruit’s management now owns a controlling interest in IGNG which now owns 100% of Grapefruit’s outstanding shares. As a result, IGNG’s financial reports will consolidate both IGNG’s and Grapefruit’s balance sheet, statement of operation and statement of cash flows and IGNG and Grapefruit will be operated as a single company. IGNG intends to change its name to Grapefruit and to obtain a more appropriate trading symbol as soon as possible. Hereinafter the combined companies will be referred to as “Grapefruit” or the “Company.”

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds licenses to both manufacture and distribute cannabis products which were originally issued in January 2018 and is fully compliant with all applicable laws and regulations to operate its cannabis manufacturing and distribution businesses.

The company is well-focused on sourcing only the “best of the best” raw cannabis materials to create the highest quality, most-trusted and consistent recreational and medical cannabis products for its customers. Grapefruit is committed to ensuring class-leading quality by rigorously testing the purity and potency of its raw materials throughout the manufacturing process and distribution chain.

Grapefruit owns and operates its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. The company’s extraction lab produces high quality, cannabis-derived distillate, also known as “honey oil,” from cannabis flower and “trim.” THC honey oil is one of base cannabis commodities which serves as the active ingredient in everything from infused edibles and tinctures/creams to the cartridges used in vapes and e-cigarettes. Honey oil often sells on the wholesale marketplace for thousands of dollars per liter, with pricing being dependent on quantity purchased, as well as other market factors such as the availability and cost of the underlying flowers and/or trim.

Grapefruit began its extraction operations in May 2019. Plans are in place to expand its honey oil production through the purchase of additional distillation equipment, which is expected to significantly increase the company’s production capacity by the fourth quarter of 2019. Grapefruit’s extraction lab is fully scalable and expansion will be built-out on a two-acre lot owned by Grapefruit at the Coachillin’ site adjacent to its current manufacturing and distribution operation.

Grapefruit selected the City of Desert Hot Springs for its cannabis extraction laboratory, because the city has created a friendly business environment for cannabis-based manufacturers, including incentives like the absence of taxes on cannabis oil production revenues. This affords Grapefruit a fundamental competitive market advantage over other Honey Oil producers.

The California cannabis regulatory scheme is unique in that it requires all cultivators (cannabis farms) and manufacturers (whether producing oils/distillates, infused edibles, tinctures creams or other cannabis products) to sell their products into the legal cannabis wholesale and retail markets exclusively through licensed distributors such as Grapefruit. Grapefruit initially obtained its California recreational and medicinal cannabis distribution license Jan. 4, 2018. In May 2019, Grapefruit was granted its provisional distribution license which is renewable annually, thereby cementing the regulatory foundation necessary to rapidly expand its distribution business.

Grapefruit’s distribution license affords it a twofold strategic advantage: first, to market and sell its own cannabis product lines to retailers throughout California; and second, to buy and resell bulk cannabis flowers and trim as well as all other legal cannabis products to properly licensed distributors and/or retailers throughout California.

The Coachillin’ Canna-Business Park, home to Grapefruit’s current operating facilities and adjacent two-acre parcel of land, is a 160-acre, self-contained legally mapped compound providing the Company with a fully permitted and serviced physical plant from which Grapefruit intends to establish a leading position in the booming California cannabis sector. The parcel was purchased by the Company prior to the Park’s full development, and the value of the land the Company owns has conservatively since doubled in value to over $2 million. Additional long-term benefits of the Coachillin’ compound include agricultural rates for power, which are currently $0.09 per kilowatt hour; the Park’s deep-water well that fully satisfies its need for water; and security expenses shared by all resident businesses. The Coachillin’ Park’s promoters also plan to position the Park, located only 10 miles north of rapidly growing uptown Palm Springs and less than 15 miles from the site of the Coachella and Stagecoach music festivals as a must-see canna-tourism destination.

Grapefruit’s ultimate goal is to become a vertically integrated, seed-to-sale cannabis and CBD product company serving the California market. Moreover, it plans to roll-out its product lines in other states, such as Nevada, Illinois, Oregon, Colorado and Washington. Grapefruit has plans to build a large, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy, a large extraction laboratory designed to extract both THC and CBD cannabinoids via non-volatile (ethanol) and volatile (butane) processes, a manufacturing space to produce Grapefruit’s vape lines and CBD products, an FDA-certified kitchen for the production of Grapefruit edibles and a distribution facility to sell all products into the entire cannabis market. The indoor grow canopy operation will be outfitted and operated to produce ultra-high-quality flowers and buds, some of which, along with the high-quality trim resulting from cleaning and maintaining the grow, will provide biomass necessary to feed the company’s extraction laboratory. Fueled by this hand cultivated biomass, Grapefruit’s lab will continuously produce pesticide and heavy metal-free world class honey oil to both serve as the active ingredient in all of Grapefruit’s branded and unbranded products and meet the projected ever-growing demand for high quality honey oil in the California market.

Grapefruit’s motto – A High You Can Trust – embodies its philosophy and ethos, reminding consumers of the company’s commitment to manufacturing, procuring and distributing only the highest quality all-natural cannabis flower, concentrates and related products that are free from pesticides, heavy metals and bacteria. Grapefruit will target its products to all recreational cannabis enthusiasts’ as continuous, consistent cannabis products. By relentlessly adhering to these policies Grapefruit intends to become the Titleist of the Cannabis industry, known for unwavering quality and consistency.

Grapefruit is managed by a team of experts possessing the experience, skill and resources required to succeed in the competitive cannabis marketplace. Founded by brothers Bradley Yourist, CEO, and Daniel Yourist, COO, Grapefruit has expanded to become a group of industry professionals sharing a passion for all things cannabis. Both the CEO & COO are attorneys licensed to practice law the State of California who possess expert cannabis licensing and regulatory expertise and experience, which will allow Grapefruit to deftly navigate the ever changing California regulatory landscape and apply for new cannabis licenses at reduced costs when necessary, rather than having to acquire licenses that are often overvalued and/or pay outside counsel to handle such matters.

Grapefruit also has its own line of cannabis-infused concentrates and edibles. Among the brands now in stores or soon to be launched are:

  • Rainbow Dreams is a new lifestyle brand designed specifically for the recreational cannabis marketplace. The Rainbow Dreams brand captures the anything goes party vibe of the 1970s by offering an array of cannabis products, such as a line of vape carts with unique cannabis strains combined with all-natural flavors for a superior no-burn experience. Rainbow Dreams fills an important niche in the marketplace as a top shelf quality product line that is competitively priced.
  • Sugar Stoned, which Grapefruit acquired in the winter of 2018, has always been a popular cannabis edibles brand which terminated operations when recreational cannabis became legal and required a license in California. Grapefruit purchased the Sugar Stoned brand in 2019 and it is now a Grapefruit portfolio brand consisting of a premium quality cannabis-infused gummy line with eight different flavors: blue raspberry, cherry, grape, peach, pineapple, sour apple, strawberry and watermelon. Grapefruit intends to expand the brand in the near future through the release of a variety of infused cookies.

Grapefruit Boulevard Investments Inc. (IGNG), closed Monday's trading session at $0.073, off by 5.8065%, on 110,201 volume with 29 trades. The average volume for the last 3 months is 162,036 and the stock's 52-week low/high is $0.006095/$0.358999997.

Recent News

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (MCOA) was featured today in a publication from HempWireNews, examining how, ccording to new estimates by the United States Department of Agriculture (USDA), hemp sales in the U.S. could increase to $25 million by 2020. USDA also estimated that by 2022, the sales could skyrocket to $100 million.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Monday's trading session at $0.06938, up 0.40521%, on 326,894 volume with 136 trades. The average volume for the last 3 months is 432,160 and the stock's 52-week low/high is $0.023/$1.68299996.

Recent News

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) was highlighted today in a publication from Stock Market Press, examining how solar industry companies see a bright future for the solar industry in 2020.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Monday's trading session at $0.0095, off by 5.4726%, on 1,960,033 volume with 101 trades. The average volume for the last 3 months is 2,827,113 and the stock's 52-week low/high is $0.008299999/$0.028799999.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.